We take cancer personally at Henry Ford Health. Patients at our ground-breaking cancer pavilion in Detroit—and at any of our other locations across Michigan—have the access to highly advanced treatments targeted to their personal needs. With precision medicine, we can determine the most effective treatment, based on an individual’s unique DNA. Leading-edge radiation technology takes personalization even further, allowing real-time dose adjustments as the targeted tumor changes. And every patient can count on us for personal attention and emotional support at every step of the way. Our 1,450 highly skilled doctors, researchers, nurse navigators and other healthcare specialists provide world class cancer care to thousands of patients each year. Our new cancer pavilion is the heart of Henry Ford Cancer, which has locations across southeast and south central Michigan. With five hospital locations, seven additional outpatient cancer centers and dozens of aligned doctor’s offices, we can offer care close to home. We are one strong, integrated team, ensuring patients have access to the latest advances in cancer treatment, research, clinical trials and support throughout their journey. We have treated people from every state in the U.S. and every continent in the world.
Henry Ford Health + MSU Health Sciences Funds Five Cancer Research Grants to Advance Cancer Medicine, Combat Health DisparitiesJanuary 31st 2023
Henry Ford Health + Michigan State University Health Sciences announced its funding of 5 cancer research grants of up to $100,000 each. These 5 grants follow an initial wave of funding from the partnership, in which 18 pilot grants of up to $25,000 each were funded in May 2022.
Henry Ford Hospital Earns Prestigious Recognition from National Accreditation Program for Rectal CancerJanuary 10th 2023
Henry Ford Hospital has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, which was developed through a collaboration between the OSTRiCh consortium and the Commission on Cancer, a quality program of the American College of Surgeons.
Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic CancerJanuary 3rd 2023
Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.